» Articles » PMID: 33353985

Epidemiology and Management of Aortic Disease: Aortic Aneurysms and Acute Aortic Syndromes

Overview
Journal Nat Rev Cardiol
Date 2020 Dec 23
PMID 33353985
Citations 121
Authors
Affiliations
Soon will be listed here.
Abstract

The aorta is the 'greatest artery', through which oxygenated blood is delivered from the left ventricle to end organs with each cardiac cycle (200 million litres of blood transported in an average lifetime). The aorta can be affected by a wide spectrum of acute factors (such as cocaine use, weight lifting and trauma) and chronic acquired and/or genetic conditions (such as systemic arterial hypertension and phaeochromocytoma), which variously lead to increased aortic wall stress. The medial layer of the aorta can also be subject to abnormalities (such as Marfan syndrome, bicuspid aortic valve, inflammatory vasculitis, atherosclerosis and infections). Despite important advances in diagnostic and therapeutic interventions, data derived from registries and population-based studies highlight that the burden of aortic diseases remains high. Therefore, specific resources need to be allocated to design and implement preventive strategies (healthy lifestyles, modifications to cardiovascular risk factors, and educational and screening programmes) at individual and community levels. In this Review, we discuss the epidemiology, management and outcomes of the most common aortic diseases, namely, aortic aneurysms and acute aortic syndromes.

Citing Articles

Aortic Remodeling in Patients with Arterial Hypertension: Pathophysiological Mechanisms, Therapeutic Interventions and Preventive Strategies-A Position Paper from the Heart and Hypertension Working Group of the Italian Society of Hypertension.

Mancusi C, Basile C, Fucile I, Palombo C, Lembo M, Buso G High Blood Press Cardiovasc Prev. 2025; .

PMID: 40082374 DOI: 10.1007/s40292-025-00710-3.


Causal role of mitochondrial proteins in aortic aneurysms: Evidence from Mendelian randomization, transcriptomic analysis, and experimental validation.

Abodulikemu A, Li L, Juaiti M Medicine (Baltimore). 2025; 104(10):e41757.

PMID: 40068065 PMC: 11902946. DOI: 10.1097/MD.0000000000041757.


Identification of the CeRNA axis of circ_0000006/miR-483-5p/KDM2B in the progression of aortic aneurysm to aorta dissection.

Liu Y, Tan X, Wang L, Jin W, He Y, Yan Y BMC Cardiovasc Disord. 2025; 25(1):141.

PMID: 40021969 PMC: 11869725. DOI: 10.1186/s12872-025-04598-8.


Utilizing Integrated Bioinformatics Analysis to Explore Potential Alterations in Mitochondrial Function Within Immune Cells Associated with Thoracic Aortic Aneurysms.

Guan C, Chen S, Huang C, Du Y, Wang K, Li P Bioengineering (Basel). 2025; 12(2).

PMID: 40001716 PMC: 11852063. DOI: 10.3390/bioengineering12020197.


Hemodynamic disturbance and mTORC1 activation: Unveiling the biomechanical pathogenesis of thoracic aortic aneurysms in Marfan syndrome.

Liu M, Wang M, Liu J, Sun A, He C, Cong X J Pharm Anal. 2025; 15(2):101120.

PMID: 39989903 PMC: 11847113. DOI: 10.1016/j.jpha.2024.101120.


References
1.
Erbel R, Aboyans V, Boileau C, Bossone E, Di Bartolomeo R, Eggebrecht H . 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the.... Eur Heart J. 2014; 35(41):2873-926. DOI: 10.1093/eurheartj/ehu281. View

2.
Hiratzka L, Bakris G, Beckman J, Bersin R, Carr V, Casey Jr D . 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice.... Circulation. 2010; 121(13):e266-369. DOI: 10.1161/CIR.0b013e3181d4739e. View

3.
Bossone E, LaBounty T, Eagle K . Acute aortic syndromes: diagnosis and management, an update. Eur Heart J. 2017; 39(9):739-749d. DOI: 10.1093/eurheartj/ehx319. View

4.
Lee C, Lee M, Hsieh R, Porta L, Lee W, Lee S . Oral Fluoroquinolone and the Risk of Aortic Dissection. J Am Coll Cardiol. 2018; 72(12):1369-1378. DOI: 10.1016/j.jacc.2018.06.067. View

5.
Sampson U, Norman P, Fowkes F, Aboyans V, Song Y, Harrell Jr F . Global and regional burden of aortic dissection and aneurysms: mortality trends in 21 world regions, 1990 to 2010. Glob Heart. 2014; 9(1):171-180.e10. DOI: 10.1016/j.gheart.2013.12.010. View